Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CERENOME, INC.CNSY · Entity 7637 | Director | October 01, 2026 | October 01, 2026 |
| Savara IncSVRA · Entity 4900 | Director | December 09, 2025 | December 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CERENOME, INC.
Report date October 01, 2026 · Filed October 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,843 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Exercise / conversion · Acquired 921 · Balance 1,843 F2: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 1,843 |
Reported balance
After 2026-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-01 · Exercise / conversion · Disposed 921 · Balance 1,843 F2: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
F2: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.
Savara Inc
Report date December 09, 2025 · Filed December 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 102,500 |
Reported balance
After 2025-12-09 transaction · row 1
1 source rowRow 1 · 2025-12-09 · Grant · Acquired 40,000 · Balance 102,500 F1: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LUMOS PHARMA, INC.
Report date December 12, 2024 · Filed December 13, 2024
Section 16 reporting ended · disclosed 2024-12-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 1
1 source rowRow 1 · 2024-12-12 · Disposition to issuer · Disposed 1,100 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.42 · Expires 2033-05-09 | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-12-12 · Disposition to issuer · Disposed 3,345 · Balance 0 F2: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.35 · Expires 2034-06-04 | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-12-12 · Disposition to issuer · Disposed 3,328 · Balance 0 F2: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.18 · Expires 2032-05-04 | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-12-12 · Disposition to issuer · Disposed 3,431 · Balance 0 F3: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.36 · Expires 2031-05-19 | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-12-12 · Disposition to issuer · Disposed 2,910 · Balance 0 F3: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.86 · Expires 2031-02-15 | Direct | 0 |
Reported balance
After 2024-12-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-12-12 · Disposition to issuer · Disposed 5,729 · Balance 0 F3: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share.
F2: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option.
F3: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 1, 2026 16:00 UTC | CERENOME, INC. CNSY · Entity 7637 | Exercise / conversionRestricted Stock Units · Derivative | 921 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-409859 · ownership.xml · derivative · entry 2 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843 Underlying: Common Stock · 921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. F2 · derivative.expiration_date: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. Read SEC document |
| October 01, 2026 Filed Oct 1, 2026 16:00 UTC | CERENOME, INC. CNSY · Entity 7637 | Exercise / conversionCommon Stock | 921 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-409859 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 20:30 UTC | CERENOME, INC. PSTV · Entity 7637 | Exercise / conversionRestricted Stock Units · Derivative | 922 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-292643 · ownership.xml · derivative · entry 2 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,764 Underlying: Common Stock · 922 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. F2 · derivative.expiration_date: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 20:30 UTC | CERENOME, INC. PSTV · Entity 7637 | Exercise / conversionCommon Stock | 922 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-292643 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:13 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 3,686 | $0.00 Strike: $5.76 | $0.00 |
DisclosureSEC source: 0001193125-26-228933 · ownership.xml · derivative · entry 2 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,686 Underlying: Common Stock · 3,686 shares Expires 2036-05-14 F2 · derivative.exercise_date: The options vest monthly over 12 months from the grant date in substantially equal monthly increments, provided that the options vest in full on the Issuer's 2027 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:13 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantRestricted Stock Units · Derivative | 3,686 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-228933 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,686 Underlying: Common Stock · 3,686 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs awarded vest ratably over four quarters in substantially equal 1/4th increments, commencing with 1/4th vesting on July 1, 2026 and the remainder vesting quarterly thereafter. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:48 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-316307 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 9, 2026, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:29 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 297,794 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0000950170-25-109408 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,794 Underlying: Common Stock · 297,794 shares Expires 2035-08-12 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:30 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 40,122 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0000950170-25-024341 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,122 Underlying: Common Stock · 40,122 shares Expires 2035-02-17 F1 · derivative.exercise_date: 1. The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's 2026 Annual Stockholder Meeting, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerStock Option (Right to Buy) · Derivative | 5,729 | Not disclosed Strike: $17.86 | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · derivative · entry 6 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,729 shares Expires 2031-02-15 F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerStock Option (Right to Buy) · Derivative | 2,910 | Not disclosed Strike: $10.36 | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · derivative · entry 5 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,910 shares Expires 2031-05-19 F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerStock Option (Right to Buy) · Derivative | 3,431 | Not disclosed Strike: $8.18 | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · derivative · entry 4 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,431 shares Expires 2032-05-04 F3 · price: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. F3 · derivative.exercise_date: Represents an out-of-money option that was cancelled without any cash payment or issuance of CVRs being made in respect thereof pursuant to the Merger Agreement. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerStock Option (Right to Buy) · Derivative | 3,328 | Not disclosed Strike: $2.35 | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · derivative · entry 3 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,328 shares Expires 2034-06-04 F2 · price: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. F2 · derivative.exercise_date: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerStock Option (Right to Buy) · Derivative | 3,345 | Not disclosed Strike: $3.42 | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · derivative · entry 2 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,345 shares Expires 2033-05-09 F2 · price: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. F2 · derivative.exercise_date: This option was cancelled pursuant to the Merger Agreement in exchange for (i) an amount in cash equal to the product of (x) the total number of shares underlying such option multiplied by (y) the excess of the Cash Amount over the applicable exercise price per share and (ii) one CVR for each share underlying such in-the-money option. Read SEC document |
| December 12, 2024 Filed Dec 13, 2024 21:31 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | Disposition to issuerCommon Stock | 1,100 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001126234-24-000118 · wk-form4_1734143505.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger, dated October 22, 2024, by and between the Issuer, DPV Parent, Inc., DPV MergerSub, Inc. and Double Point Ventures LLC ("DPV") (the "Merger Agreement") in exchange for (i) $4.25 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share. Read SEC document |
| December 12, 2024 Filed Dec 16, 2024 22:47 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-136773 · ownership.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 12, 2025, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The reporting person has elected to defer receipt of the shares of common stock underlying the RSUs upon vesting. In accordance with the reporting person's deferral election, the vested shares will be delivered to the reporting person following the reporting person's termination of service with the Issuer. Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 20:30 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 3,650 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0000950170-24-105960 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,650 Underlying: Common Stock · 3,650 shares Expires 2034-09-11 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:08 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | GrantStock Option (Right to Buy) · Derivative | 3,328 | $0.00 Strike: $2.35 | $0.00 |
DisclosureSEC source: 0001126234-24-000078 · wk-form4_1717790876.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,328 Underlying: Common Stock · 3,328 shares Expires 2034-06-04 F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:24 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $2.03 | $0.00 |
DisclosureSEC source: 0000950170-24-020414 · ownership.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 2,250 shares Expires 2034-02-22 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| December 14, 2023 Filed Dec 15, 2023 22:35 UTC | Savara Inc SVRA · Entity 4900 | GrantCommon Stock | 22,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-058846 · doc4.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 F1 · shares: Represents restricted stock units ("RSUs") that vest in full on December 14, 2024, subject to the reporting person's continued service with the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| May 10, 2023 Filed May 12, 2023 17:45 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | GrantStock Option (Right to Buy) · Derivative | 3,345 | $0.00 Strike: $3.42 | $0.00 |
DisclosureSEC source: 0001126234-23-000073 · wf-form4_168392789999366.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,345 Underlying: Common Stock · 3,345 shares Expires 2033-05-09 F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:30 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 20,182 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001209191-23-010639 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,182 Underlying: Common Stock · 20,182 shares Expires 2033-02-15 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:11 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001209191-22-061421 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2032-12-13 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 13, 2023. Read SEC document |
| May 05, 2022 Filed May 9, 2022 17:11 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | GrantStock Option (Right to Buy) · Derivative | 3,431 | $0.00 Strike: $8.18 | $0.00 |
DisclosureSEC source: 0001126234-22-000057 · wf-form4_165213064162936.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,431 Underlying: Common Stock · 3,431 shares Expires 2032-05-04 F1 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2009 Equity Incentive Plan (the "Plan"). One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant. Read SEC document |
| December 14, 2021 Filed Dec 14, 2021 23:32 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001209191-21-069588 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-12-14 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 14, 2022. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:17 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 6,336 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001209191-21-036242 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,336 Underlying: Common Stock · 6,336 shares Expires 2031-05-25 F1 · derivative.exercise_date: The options vest monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the options vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date or, if earlier, such annual meeting. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:37 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | GrantStock Option (Right to Buy) · Derivative | 2,910 | $0.00 Strike: $10.36 | $0.00 |
DisclosureSEC source: 0001126234-21-000083 · wf-form4_162189581801877.xml · derivative · entry 2 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,910 Underlying: Common Stock · 2,910 shares Expires 2031-05-19 F3 · derivative.exercise_date: Grant to the Reporting Person of a nonstatutory stock option under the Plan. One hundred percent (100%) of the shares shall vest on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, in each case subject to the Reporting Person's continuous service as of such date. The option expires ten years after the date of grant. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:37 UTC | LUMOS PHARMA, INC. (LUMO) · Entity 85102 | GrantCommon Stock | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0001126234-21-000083 · wf-form4_162189581801877.xml · nonDerivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 F1 · shares: Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2010 Non-Employee Director Stock Award Plan (the "Plan") that were received as an award, for no consideration. The RSUs vest in a single installment on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the first Annual Meeting following the date of grant, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. F2 · balance_after: Includes 733 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of three successive annual installments with the next installment occurring on February 16, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 17:19 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001209191-20-063976 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable on December 16, 2021. Read SEC document |
| June 25, 2020 Filed Jul 1, 2020 13:55 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (Right to Buy) · Derivative | 34,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001209191-20-039563 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 34,000 shares Expires 2030-06-25 F1 · derivative.exercise_date: The options vest in equal 1/19th increments on the 9th of every month with the first 1/19th increment vesting on July 9, 2020 and the last 1/19th increment vesting on January 9, 2022. Read SEC document |
| January 09, 2020 Filed Jan 23, 2020 00:21 UTC | CERENOME, INC. PSTV · Entity 7637 | GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.57 | $0.00 |
DisclosureSEC source: 0001209191-20-004536 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: The option vests over two years as follows: 50% of the shares vest on January 1, 2021 and 1/24th of the shares vest each monthly anniversary thereafter. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 23:00 UTC | Savara Inc SVRA · Entity 4900 | GrantStock Option (Right to Buy) · Derivative | 12,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0000899243-19-030068 · doc4.xml · derivative · entry 1 van Es-Johansson An · CIK 0001795902 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-12-20 F1 · derivative.exercise_date: The shares subject to the option vest and become exercisable in twelve equal installments on each quarterly anniversary of December 20, 2019, subject to the reporting person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.